Blitz Bureau
New Delhi: India must have a robust drug regulation framework to maintain the title ‘pharmacy of the world’, said Union Health Minister, JP Nadda on July 17. Nadda said this at a high-level review meeting on regulation of drugs, cosmetics, and medical devices, in the national Capital on Wednesday.
“For India to become the global leader in drug regulation to match our global reputation of ‘Pharmacy of the World’, we need to have a world-class regulatory framework matching our scale of operations and international expectations,” Nadda said.
This comes as contaminations were detected in several India-made drugs recently by the US Food and Drug Administration and European Medicines Agency, among others. Highlighting the global position of India as the leading producer and exporter of drugs, Nadda urged the Central Drugs Standard Control Organisation (CDSCO) to draw a road map with timelines for achieving global standards in its mandated activities.
Nadda also stated that the upscaling “needs to be systems-based focussing on highest standards of uniformity, technical upgradation, and futuristic approach”.
